Valion Bio VBIO
Valion Bio Reports First Quarter 2026 Financial Results
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001437749-26-017082
- Reports quarterly results (2.02)
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Healthy Extracts HYEX public float $4M, Jun 30, 2025
- Theriva Biologics TOVX public float $4M, Jun 30, 2025
- Jaguar Health JAGX public float $4M, Jun 30, 2025
- China Pharma Holdings CPHI public float $4M, Jun 30, 2025
- Synlogic SYBX public float $4M, Jun 30, 2025